1，6二磷酸果糖及磷酸肌酸治疗儿童病毒性心肌炎的疗效分析

刘品茹

（陕西蒲城县第二医院儿科，陕西 渭南，715500）

浏览次数：188次 下载次数：507次

摘要：

目的 探究1,6二磷酸果糖和磷酸肌酸治疗儿童病毒性心肌炎的临床效果。方法 选择我院2015年1月至2016年10月收治的儿童病毒性心肌炎患儿80例，并将其均分为对照组和观察组。对照组40例患儿采用1,6二磷酸果糖治疗，观察组40例患儿采用磷酸肌酸治疗。观察比较两组患儿的心功能相关指标及治疗效果。结果 治疗前，两组患儿的CK-MB、cTnT、
cTnI水平无显著性差异（P>0.05）；治疗后，两组患儿的CK-MB、cTnT、cTnI水平均较治疗前明显改善，且观察组的cTnT、cTnI水平均优于对照组（P<0.05），但两组的CK-MB水平无显著性差异（P>0.05）。观察组患儿的治疗总有效率为87.50%，明显高于对照组的70.00%（P<0.05）。结论 儿童病毒性心肌炎一经诊断应该及时对患儿进行治疗，就磷酸肌酸、1,6二磷酸果糖两种药物而言，磷酸肌酸能够获得较好的临床治疗效果，值得在临床上推广使用。

关键词：儿童病毒性心肌炎；1,6 二磷酸果糖；磷酸肌酸

中图分类号：R725.4文献标志码：A文章编号：2096-1413(2017)14-0095-02

Efficacy analysis of 1,6-diphosphofructose and phosphocreatine in the treatment of children with viral myocarditis
LIU Pin-ru
(Department of Pediatrics, the Second Hospital of Pucheng County, Weinan 715500, China)

ABSTRACT: Objective To investigate the effect of 1,6 -diphosphofructose and phosphocreatine in the treatment of children with viral myocarditis. Methods From January 2015 October to 2016, 80 cases of children with viral myocarditis in our hospital were selected as research subjects and equally divide into control group and observation group. 40 cases in the control group received 1,6-diphosphofructose and Fourty cases in the observation group accepted phosphocreatine. The cardiac function related indicators and therapeutic effect were compared and observed between the two groups. Results Before treatment, there were no significant differences in the levels of CK-MB, cTnT and cTnI between the two groups (P>0.05); after treatment, the levels of CK-MB, cTnT and cTnI were improved of the two groups, and the levels of cTnT and cTnI in the observation group were better than those of the control group (P<0.05), but there was no significant difference in the level of CK-MB between the two groups. The total effective rate of the observation group was 87.50%, which was better than 70.00% of the control group (P<0.05). Conclusion Children with viral myocarditis should be timely receive treatment after diagnosis, for the two drugs of 1,6-diphosphofructose and phosphocreatine, the phosphocreatine has better treatment effect, which is worthy of clinical promotion.
KEYWORDS: children with viral myocarditis; 1,6-diphosphofructose; phosphocreatine

参考文献：
[1] 周华,朱飞.黄芪注射液联合1,6-二磷酸果糖对小儿病毒性心肌炎免疫功能及治疗效果的影响[J].现代实用医学,2016,28(2):244-245.
[2] 吴鹏,陈国辉.1,6 二磷酸果糖联合黄芪注射液治疗儿童病毒性心肌炎的疗效观察[J].中国医药指南,2016,14(11):76-77.
[3] 蹇友志.磷酸肌酸与果糖二磷酸钠治疗小儿心肌炎疗效对比观察[J].航空航天医学杂志,2015,26(10):1250-1251.
[4] 戴春威.对比分析磷酸肌酸钠和果糖二磷酸钠治疗小儿心肌炎的可行性及安全性[J].临床医学研究与实践,2016,1(15):82.
[5] 曾坚,李亚钦.病毒唑联合果糖二磷酸钠治疗病毒性心肌炎51例的临床观察[J].广东医学院学报,2013,31(4):447-449.
[6] 班存芳,胡令英.病毒性心肌炎患儿采用磷酸肌酸钠治疗对心功能预后的影响[J].中国处方药,2016,14(9):78-80.